SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of Report (Date of earliest event reported): May 13, 2004


                           DRAGON PHARMACEUTICAL INC.
               (Exact Name of Registrant as Specified in Charter)


           Florida                        0-27937                65-0142474
-------------------------------   ------------------------ ---------------------
(State or Other Jurisdiction of   (Commission File Number)      (IRS Employer
         Incorporation)              Identification No.)


          1055 Hastings Street, Suite 1900
              Vancouver, British Columbia                         V6E 2E9
      ---------------------------------------                    ---------
      (Address of Principal Executive Offices)                   (Zip Code)




       Registrant's telephone number, including area code: (604) 669-8817

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)


<PAGE>

Item 7. Financial Statements and Exhibits

          (c)  Exhibits

               99.1 Press release dated May 13, 2004

Item 12. Results of Operations and Financial Condition

     The purpose of this current  report on Form 8-K is to disclose  that Dragon
Pharmaceutical  Inc.  issued a press  release  on May 13,  2004  announcing  and
summarizing its financial  results for the  three-month  period ending March 31,
2004.



                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                     DRAGON PHARMACEUTICAL INC.


Date: May 14, 2004                   By:    /s/ Matthew Kavanagh
                                            ------------------------------------
                                     Name:  Matthew Kavanagh
                                     Title: Director of Finance and Compliance
                                            (Principal Financial and Accounting
                                            Officer)
[{"type": "8-K", "sequence": "1", "filename": "form8k051504.txt", "description": "FORM 8-K FOR PRESS RELEASE RE 1ST QUARTER RESULTS", "secsgml_size_bytes": 2424}]
{"company-data": {"conformed-name": "DRAGON PHARMACEUTICALS INC", "cik": "0001075206", "assigned-sic": "2834", "irs-number": "650142474", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-27937", "film-number": "04808968"}, "business-address": {"street1": "543 GRANVILLE STREET SUITE 1200", "city": "VANCOUVER BC V6C 1X8", "state": "A1"}, "mail-address": {"street1": "543 GRANVILLE STREET SUITE 1200", "street2": "VANCOUVER BRITISH COLUMBIA CANADA V6C1X", "city": "VANCOUVER BRITISH CO"}}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of Report (Date of earliest event reported): May 13, 2004

                           DRAGON PHARMACEUTICAL INC.
               (Exact Name of Registrant as Specified in Charter)

           Florida                        0-27937                65-0142474
-------------------------------   ------------------------ ---------------------
(State or Other Jurisdiction of   (Commission File Number)      (IRS Employer
         Incorporation)              Identification No.)

          1055 Hastings Street, Suite 1900
              Vancouver, British Columbia                         V6E 2E9
      ---------------------------------------                    ---------
      (Address of Principal Executive Offices)                   (Zip Code)

       Registrant's telephone number, including area code: (604) 669-8817

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)
Item 7. Financial Statements and Exhibits

          (c)  Exhibits

               99.1 Press release dated May 13, 2004

Item 12. Results of Operations and Financial Condition

     The purpose of this current  report on Form 8-K is to disclose  that Dragon
Pharmaceutical  Inc.  issued a press  release  on May 13,  2004  announcing  and
summarizing its financial  results for the  three-month  period ending March 31,
2004.

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                     DRAGON PHARMACEUTICAL INC.

Date: May 14, 2004                   By:    /s/ Matthew Kavanagh
                                            ------------------------------------
                                     Name:  Matthew Kavanagh
                                     Title: Director of Finance and Compliance
                                            (Principal Financial and Accounting
                                            Officer)